期刊文献+

腹泻型肠易激综合征患者结肠黏膜Toll样受体4信号通路的研究 被引量:2

An investigation of signal transduction pathway of colonic mucosal toll-like receptor 4 in patients with diarrhea-irritable bowel syndrome
原文传递
导出
摘要 目的 研究Toll样受体4(TLR4)、CD14、髓样分化蛋白-2(MD-2)及NF-κB在腹泻型肠易激综合征(IBS-D)患者结肠黏膜的表达,了解TLR4/NF-κB信号传导通路及其在IBS致病机制中的作用.方法 采用免疫组化法半定昔分析30例IBS-D患者及12名健康志愿者结肠黏膜TLR4、CD14MD-2和NF-κB的表达情况.结果 免疫组化结果显示,IBS-D组TLR4的吸光度[A值,(0.3971±0.0996)]高于健康对照组(0.3044±0.0481);IBS-D组的NF-κB阳性率及强度均比健康对照组增高;IBS-D组的黏膜固有层MD-2阳性细胞数高于健康对照组,固有层CD14阳性率高于健康对照组,差异均有统计学意义.两组的肠上皮细胞中MD-2和CD14均为低表达或无表达.结论 IBS-D患者的肠道黏膜存在TLR4/NF-κB信号传导通路的活化,TLR4在IBS-D发病中具有一定作用. Objective To study the expressions of TLR4, CD14, MD-2 and NF-kB in colonic mucosa in patients with diarrhea-irritable bowel syndrome (IBS-D) , and compared with normal subjects. The purpose of this study is to explore the role of TLR4 and TLR4 signal transduction pathway in the pathogenesis of IBS-D. Methods The expressions of TLR4, CD14, MD-2 and NF-kB in colon mucosa were examined by immunohistochemistry (IHC) in 30 IBS-D patients and 12 healthy volunteers separately. The average absorbance (A value) of TLR4 was analyzed. The positive expression rates of CD14, MD-2 and NF-kB of colonic mucosa were studied. Results Compared with healthy controls, significant upregulation of TLR4 expression relative to controls was found in colon mucosa of IBS-D. A value of TLR4 in IBS-D was significantly higher (0.3971 ±0.0996 vs 0. 3044 ±0.0481). The positive rate and intensity of NF-kB in IBS-D were significantly higher than those in healthy. The number of positive cells of MD-2 showed significant increase in lamina propria of IBS-D against controls. The percent of CD14 positive was upregulated in lamina propria in IBS-D. The expressions of MD-2 and CD14 in intestine epithelial cell were low or negative. Conclusions There is the activation of the signal transduction pathway of TLR4/NF-kB in the colonic mucosa of patients with IBS-D. Up-regulated expression of TLR4 in IBS patients suppose that it might contribute to occurrence of IBS-D.
出处 《中华内科杂志》 CAS CSCD 北大核心 2010年第6期491-494,共4页 Chinese Journal of Internal Medicine
关键词 肠易激综合征 TOLL样受体4 淋巴细胞抗原96 NF-ΚB 抗原 CD14 Irritable bowel syndrome Toll-like receptor 4 Lymphocyte antigen 96 NF-kappa B Antigens,CD14
  • 相关文献

参考文献10

  • 1Campbell N,Yio XY,So LP,et al.The intestinal epithelial cell:processing and presentation of antigen to the mucosal immune system.Immunol Rev,1999,172:315-324.
  • 2王雪梅,刘玉兰.肠易激综合征腹泻型患者结肠黏膜Toll样受体2和4的表达[J].中华消化杂志,2009,29(2):105-108. 被引量:14
  • 3Drossman DA.The functional gastrointestinal disorders and the Rome Ⅲ process.Gastroenterology,2006,130:1377-1390.
  • 4Oostenbrug LE,Drenth JP,de Jong DJ,et al.Association between Toll-like receptor 4 and inflammatory bowel disease.Inilamm Bowel Dis,2005,11:567-575.
  • 5Bercik P,Verdu EF,Collins SM.Is irritable bowel syndrome a low-grade inflammatory bowel disease? Gastroenterol Clin North Am,2005,34:235-245.
  • 6Abreu MT,Thomas LS,Arnold ET,et al.TLR signaling at the intestinal epithelial interface.J Endotoxin Res,2003,9:322-330.
  • 7Abreu MT,Arnold ET,Thomas LS,et al.TLR4 and MD-2 expression is regulated by immune-mediated signals in human intestinal epithelial cells.J Biol Chem,2002,277:20431-20437.
  • 8Haziot A,Ferrero E,K(o)ntgen F,et al.Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice.Immunity,1996,4:407-414.Haziot A,Ferrero E,K(o)ntgen F,et al.Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice.Immunity,1996,4:407-414.
  • 9Frolova L,Drastich P,Rossmann P,et al.Expression of Toll-like receptor 2 (TLR2),TLR4,and CD14 in biopsy samples of patients with inflammatory bowel diseases:upregulated expression of TLR2 in terminal ileum of patients with ulcerative colitis.J Histochem Cytochem,2008,56:267-274.
  • 10Schreiber S,Nikolaus S,Hampe J.Activation of nuclear factor kappa B inflammatory bowel disease.Gut,1998,42:477-484.

二级参考文献9

  • 1刘新光.解读功能性肠病罗马Ⅲ诊断标准[J].中国实用内科杂志,2006,26(11):1691-1693. 被引量:109
  • 2Drossman DA. The functional gastrointestinal disorders and the Rome Ⅲ process. Gastroenterology, 2006, 130: 1377- 1390.
  • 3Dupont AW. Post-infectious irritable bowel syndrome. Curr Gastroenterol Rep, 2007,9 : 378-384.
  • 4Longstreth GF, Hawkey CJ, Mayer EA, et al. Characteristics of patients with irritable bowel syndrome recruited from three sources: implications for clinical trials. Aliment Pharmacol Ther, 2001,15 :959-964.
  • 5Fukata M, Abreu MT. Role of Toll like receptors in gastrointestinal malignancies. Oneogene, 2008,27 :234-243.
  • 6Cario E, Podolsky DK. Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun, 2000, 68,7010-7017.
  • 7Toiyama Y, Araki T, Yoshiyama S, et al. The expression patterns of Toll-like receptors in the ileal pouch mueosa of postoperative ulcerative colitis patients. Surg Today, 2006, 36: 287-290.
  • 8Furrie E, Macfarlane S, Thomson G, et al. Toll-like receptors-2, -3 and -4 expression patterns on human colon and their regulation by mucosal associated bacteria. Immunology, 2005,115 : 565-574.
  • 9Frolova L, Drastich P, Rossmann P, et al. Expression of Toll-like receptor 2 (TLR2), TLR4, and CD14 in biopsy samples of patients with inflammatory bowel diseases: upregulated expression of TLR2 in terminal ileum of patients with ulcerative colitis. J Histochem Cytochem, 2008, 56: 267-274.

共引文献13

同被引文献36

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部